KLK3 and pachyonychia congenita: However, in men with high-risk localized PC—defined by a Gleason score of 8–10, prostate-specific antigen (PSA) levels greater than 20 ng/mL, or cT2c or higher—there is a heightened risk of disease recurrence after definitive treatment [6].